Acadia Healthcare Company, Inc.

For the period ended Mar 31, 2026. Filed Apr 30, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed Apr 30, 2026

ACHC$38.64+0.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Equity (Unaudited)

Condensed Consolidated Statements of Equity

(In thousands)

Common Stock · Additional · Retained Earnings
Shares · Amount · Paid-in Capital · (Accumulated Deficit) · Total
Balance at December 31, 2024	91,775	$918		$2,685,464		$387,333		$3,073,715
Common stock issued under stock incentive plans	217	2		(2)		—		—
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises	—	—		(1,936)		—		(1,936)
Repurchase of common stock, including excise tax	(1,603)	(16)		—		(47,256)		(47,272)
Equity-based compensation expense	—	—		8,677		—		8,677
Net income attributable to Acadia Healthcare Company, Inc.	—	—		—		8,374		8,374
Balance at March 31, 2025	90,389	904		2,692,203		348,451		3,041,558
Common stock issued under stock incentive plans	109	1		(1)		—		—
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises	—	—		(1,780)		—		(1,780)
Repurchase of common stock, including excise tax	(104)	(1)		—		(3,159)		(3,160)
Equity-based compensation expense	—	—		10,549		—		10,549
Other	—	—		692		—		692
Net income attributable to Acadia Healthcare Company, Inc.	—	—		—		30,127		30,127
Balance at June 30, 2025	90,394	904		2,701,663		375,419		3,077,986
Common stock issued under stock incentive plans	38	—		—		—		—
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises	—	—		(237)		—		(237)
Repurchase of common stock, including excise tax			—		9		9
Equity-based compensation expense	—	—		6,031		—		6,031
Other	—	—		262		—		262
Net income attributable to Acadia Healthcare Company, Inc.	—	—		—		36,246		36,246
Balance at September 30, 2025	90,432	904		2,707,719		411,674		3,120,297
Common stock issued under stock incentive plans	21	1		(1)		—		—
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises	—	—		(273)		—		(273)
Repurchase of common stock, including excise tax	—	—		—		4		4
Equity-based compensation expense	—	—		6,451		—		6,451
Net loss attributable to Acadia Healthcare Company, Inc.	—	—		—		(1,177,519)		(1,177,519)
Balance at December 31, 2025	90,453	905		2,713,896		(765,841)		1,948,960
Common stock issued under stock incentive plans	311	3		(3)		—		—
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises	—	—		(2,744)		—		(2,744)
Equity-based compensation expense	—	—		7,956		—		7,956
Net income attributable to Acadia Healthcare Company, Inc.	—	—		—		4,105		4,105
Balance at March 31, 2026	90,764	$908		$2,719,105		$(761,736)		$1,958,277

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.